Tectonic Therapeutic | AVRO - Ebit

Aktienkurs
30.00
Täglich Wechseln
-0.83 -2.69%
Monatlich
41.58%
Jährlich
41.84%
Q1 Prognose
32.30




Ebit Veränderung Datum
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
MacroGenics USD -12.1M 32.26M 2025-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pfizer USD 4.65B 71M 2025-12
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 19.18M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Takeda JPY 257.49B 568.56B 2025-12
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 501.33M 15.6M 2025-09